<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>bioMérieux S.A. &#8211; 元哲咨询</title>
	<atom:link href="https://www.yuanzhezixun.com/tag/biomerieux-s-a/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.yuanzhezixun.com</link>
	<description>行业研究专家</description>
	<lastBuildDate>Wed, 13 Oct 2021 05:51:51 +0000</lastBuildDate>
	<language>zh-Hans</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://www.yuanzhezixun.com/wp-content/uploads/2021/10/cropped-shcrilogo-c-45x45.jpg</url>
	<title>bioMérieux S.A. &#8211; 元哲咨询</title>
	<link>https://www.yuanzhezixun.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>2020-2030年全球体细胞基因检测市场分析及预测报告：预计将以9.3%的年复合增长率增长</title>
		<link>https://www.yuanzhezixun.com/2020-2030nianquanqiutixibaojiyinjianceshichangfenxijiyucebaogao/</link>
		
		<dc:creator><![CDATA[Timlee]]></dc:creator>
		<pubDate>Tue, 12 Oct 2021 08:50:37 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[报告速递]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[Agilent Technologies]]></category>
		<category><![CDATA[Arup Laboratories]]></category>
		<category><![CDATA[ASURAGEN]]></category>
		<category><![CDATA[bioMérieux S.A.]]></category>
		<category><![CDATA[Centogene N.V.]]></category>
		<category><![CDATA[CIRCULOGENE Theranostics]]></category>
		<category><![CDATA[dPCR]]></category>
		<category><![CDATA[Guardant Health]]></category>
		<category><![CDATA[Illumina]]></category>
		<category><![CDATA[Inc.]]></category>
		<category><![CDATA[Invivoscribe]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[Mission Bio]]></category>
		<category><![CDATA[NeoGenomics Laboratories]]></category>
		<category><![CDATA[NGS]]></category>
		<category><![CDATA[Roche]]></category>
		<category><![CDATA[RT-PCR]]></category>
		<category><![CDATA[体外诊断]]></category>
		<category><![CDATA[体细胞基因检测]]></category>
		<category><![CDATA[体细胞基因检测区域分析]]></category>
		<category><![CDATA[体细胞基因检测市场份额]]></category>
		<category><![CDATA[体细胞基因检测市场竞争]]></category>
		<category><![CDATA[体细胞基因检测市场细分]]></category>
		<category><![CDATA[体细胞基因检测市场规模]]></category>
		<category><![CDATA[体细胞基因测试]]></category>
		<category><![CDATA[医疗服务]]></category>
		<category><![CDATA[华大基因]]></category>
		<category><![CDATA[基因检测]]></category>
		<category><![CDATA[大健康]]></category>
		<category><![CDATA[实体瘤]]></category>
		<category><![CDATA[微阵列]]></category>
		<category><![CDATA[测序]]></category>
		<category><![CDATA[组织样品]]></category>
		<category><![CDATA[聚合酶链式反应]]></category>
		<category><![CDATA[血液恶性肿瘤]]></category>
		<category><![CDATA[血液样品]]></category>
		<category><![CDATA[骨髓抽吸物]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=27679</guid>

					<description><![CDATA[据CRI元哲分析，体细胞基因检测行业是发展最迅速和最有活力的市场之一。2020年，全球体细胞基因检测市场规模达到了大约75.4亿美元，在2021-2030年预计将以9.3%的年复合增长率增长。

癌症基因组学领域的发展及其属性（如体细胞突变分析）对该市场产生了有利影响。此外，研究人员迅速在癌症基因组研究中使用测序仪器，并越来越重视精准医疗等关键因素预计也将促进市场增长。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
